# reload+after+2024-01-22 22:43:11.100886
address1§Chemin des Mines, 9
city§Geneva
zip§1202
country§Switzerland
phone§41 22 884 1555
fax§41 22 884 1556
website§https://www.addextherapeutics.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia, and dystonia; ADX71149 for epilepsy and undisclosed CNS disorders; and GABAB PAM for pain, anxiety, and addiction. It has license and collaboration agreement with Janssen Pharmaceuticals Inc.; Indivior PLC; and The CharcotMarieTooth Association. The company was formerly known as Addex Pharmaceuticals Ltd. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland.
fullTimeEmployees§24
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Timothy Mark Dyer', 'age': 55, 'title': 'Co-Founder, CEO & Director', 'yearBorn': 1968, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Roger G. Mills M.D.', 'age': 66, 'title': 'Chief Medical Officer & Director', 'yearBorn': 1957, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Lénaic  Teyssédou', 'age': 37, 'title': 'Head of Finance', 'yearBorn': 1986, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Jean-Philippe  Rocher Ph.D.', 'age': 64, 'title': 'Head of Discovery - Chemistry', 'yearBorn': 1959, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Robert  Lutjens', 'age': 55, 'title': 'Head of Discovery - Biology', 'yearBorn': 1968, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Mikhail  Kalinichev Ph.D.', 'age': 56, 'title': 'Head of Translational Science', 'yearBorn': 1967, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§1.644
priceToSalesTrailing12Months§3.8166893
currency§USD
dateShortInterest§1702598400
exchange§NCM
quoteType§EQUITY
shortName§Addex Therapeutics Ltd
longName§Addex Therapeutics Ltd
firstTradeDateEpochUtc§1581517800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§38807d1a-b771-3feb-99eb-88558227ef73
gmtOffSetMilliseconds§-18000000
recommendationKey§none
quickRatio§2.655
grossMargins§-2.75122
ebitdaMargins§0.0
trailingPegRatio§None
